Design and tuning of BODIPY-based dimers as long-wavelength triplet photosensitizers for targeted photodynamic therapy
Source abstract
Abstract
The development of triplet photosensitizers (PSs) fulfilling the requirements for efficiently inducing cell death via photodynamic therapy (PDT) is an active and growing research area. Herein, we propose the use of conformationally flexible, heteroatom-bridged, and constrained heteroring-fused BODIPY-based dimers as reactive oxygen species (ROS) PSs for cancer treatment. Different bridging atoms (sulfur and selenium) and molecular geometries (open-ring and annulated conformations) were explored to identify the most effective triplet PS. The required enhancement in spin-orbit coupling to foster the required triplet state population can be driven by different pathways; intramolecular charge transfer induced by the bridges, twisted aromatic frameworks in the heterocycle-fused geometries, or the heavy-atom effect of selenium. Computationally aided photophysical characterization unveils the main mechanism enabling ROS generation in each set of π-extended dimers and pinpoint to the heteroring-fused dimers as the best suited triplet PS for PDT. Among them, the selenophene-fused dimer is the most appealing one for PDT, as it enables the most efficient singlet oxygen generation under longwavelength (far red) illumination and induces human melanoma cell death under irradiation. In contrast, thiophene-fused dimers also generate singlet oxygen but require additional functionalization with biocompatibility-enhancing groups (mitochondria-targeting triphenylphosphonium cation) to elicit a photocytotoxic response in cellular environments.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Luminescence and Fluorescent Materials · Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (42)
Show source-provided references
1. Photodynamic therapy for cancer10.1038/nrc1071 ↗
2. Photodynamic therapy: a brief history10.3390/jcm8101581 ↗
3. Recent advances in photodynamic therapy for cancer and infectious diseases10.1002/wnan.1560 ↗
4. The dual role of photodynamic therapy to treat cancer and microbial infection10.1016/j.drudis.2024.104099 ↗
5. Recent advances for enhanced photodynamic therapy: from new mechanism to innovative strategies
6. Photodynamic therapy – mechanism, photosensitizers and combinations10.1016/j.biopha.2018.07.049 ↗
7. BODIPY-based photodynamic agents for exclusively generating superoxide radical over singlet oxygen10.1002/anie.202106748 ↗
8. Towards overcoming obstacles of type II photodynamic therapy: endogenous production of light, photosensitizer and oxygen10.1016/j.apsb.2023.11.007 ↗
9. A heterocyclic strategy for regulating the proportion of type I and II photodynamic therapy10.1039/D4QM00399C ↗
10. Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy10.1021/acs.chemrev.1c00381 ↗
11. Versatile types of inorganic/organic NIR-IIa/IIb fluorophores: from strategic design toward molecular imaging and theranostics10.1021/acs.chemrev.1c00553 ↗
12. Photosensitization and controlled photosensitization with BODIPY dyes10.1016/j.ccr.2017.09.029 ↗
13. BODIPYs in antitumoral and antimicrobial photodynamic therapy: an integrating review10.1016/j.jphotochemrev.2019.04.001 ↗
14. Engineering of BODIPY-based theranostics for cancer therapy10.1016/j.ccr.2022.214908 ↗
15. BODIPY as multifunctional theranostic reagent in biomedicine: self-assembly, properties, and applications10.1002/adma.202207546 ↗
16. Synthesis of BODIPY dyes through postfunctionalization of the boron dipyrromethene core10.1016/j.ccr.2019.213024 ↗
17. Basic structural modifications for improving the practical properties of BODIPY10.1016/j.ccr.2022.214684 ↗
18. Evolution of BODIPY as triplet photosensitizers from homogenous to heterogeneous: the strategies of functionalization to various forms and their recent applications10.1016/j.ccr.2023.215074 ↗
19. Heavy-atom-free photosensitizers: from molecular design to applications in the photodynamic therapy of cancer10.1021/acs.accounts.0c00606 ↗
20. Recent advances in zig-zag-fused BODIPYs10.1039/D2QO01243J ↗
21. Ring-fused BODIPY derived heavy-atom-free triplet photosensitizers10.1039/D4CC06350C ↗
22. Heavy-atom-free photosensitizers with intersystem crossing mediated by intamolecular photoinduced electron transfer10.1039/C9OB02170A ↗
23. Enhancement of intersystem crossing in assymetrically substituted BODIPY photosensitizers10.1039/D4TC04850D ↗
24. Bi/oligo-BODIPYs: recent advances in design strategies of the dyes with excellent photophysical and photochemical properties for various practical tasks10.1016/j.ccr.2025.217030 ↗
25. Carbon-carbon bonded BODIPY dimers: structural classification, photophysical mechanisms, and functional applications10.1016/j.ccr.2026.217674 ↗
26. Molecular fluorophore dimerization: a new paradigm for precision phototheragnosis10.1039/D5CS01306B ↗
27. Synthesis and functionalization of new polyhalogenated BODIPY dyes. Study of their photophysical properties and singlet oxygen generation10.1016/j.tet.2011.11.070 ↗
28. Phosphorogenic dipyrrinato-iridium(III) complexes as photosensitizers for photodynamic therapy10.1016/j.dyepig.2021.109886 ↗
29. Development of geometry-controlled all-orthogonal BODIPY trimers for photodynamic therapy and phototheragnosis10.1021/acs.orglett.2c01169 ↗
30. Heavy-atom-free BODIPY-based photodynamic therapy agents activated at long wavelengths10.1039/D4MA00951G ↗
31. Intramolecular exciton coupling modulates the convergent singlet-triplet energy gap toward NIR-emissive heavy-atom-free Oligo-BODIPY photosensitizers10.1039/D5SC08201C ↗
32. Strategic construction of sulfur-bridged BODIPY dimers and oligomers as heavy-atom-free photosensitizers10.1021/acs.orglett.1c02622 ↗
33. Multifunctional broadband visible-light absorbing selenophene modified BODIPY photosensitizers10.1016/j.dyepig.2023.111392 ↗
34. Electrochemical diselenation of BODIPY fluorophores for bioimaging applications and sensitization of 1O2
35. Benzoheterocyclic [b]-fused BODIPYs: synthesis and effects of N, O, and S on structure, photophysical properties, and aggregation10.1039/D5QO01187F ↗
36. Thiophene-fused BODIPY dimers and tetramers from oxidative aromatic couplings as near-infrared dyes10.1021/acs.orglett.1c02926 ↗
37. Highly regioselective α-Chlorination of the BODIPY chromophore with Copper(II) chloride10.1021/acs.orglett.5b02383 ↗
38. Mild open-shell character of BODIPY and its impact of singlet and triplet excitation energies10.1021/acs.jctc.1c00544 ↗
39. Long-wavelength photoconvertible dimeric BODIPYs for super-resolution single-molecule localization imaging in near-infrared emission10.1021/jacs.2c08947 ↗
40. Elucidation of the intersystem crossing mechanism in a helical BODIPY for low-dose photodynamic therapy10.1002/anie.202005269 ↗
41. The role of electronic triplet states and high-lying singlet states in the deactivayion mechanism of the parent BODIPY: an ADC(2) and CASPT2 study10.1002/cptc.201800169 ↗
42. Mechanism-guided design and synthesis of a mitochondria-targeting artemisinin analogue with enhanced anticancer activity10.1002/anie.201607303 ↗